The Financial Express6d
Zydus Lifesciences soars 3% on US FDA nod for manufacturing Apalutamide Tablets
Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...
CNBCTV186d
Marksans Pharma gains 3% as UK arm secures approval for muscle relaxant tablets
Shares of Marksans Pharma were trading higher in the afternoon session on Tuesday, up 2.14% at ₹207.2 per piece on the BSE at ...
Biosimilar Market Is Projected To Grow At A 8.9% CAGR, Reaching US$ 102.68 Billion By 2034 Fact.MR Report
Greater Effectiveness and Enhanced Safety Profiles of Biosimilars Compared to Their Reference Biologics Increasing Their Adoption Worldwid ...
Here's why Zydus Lifesciences share price popped 3% in trade on March 19
The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...
Zydus Life receives USFDA approval for manufacturing Apalutamide tablets, 60 mg
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.
Zydus Lifesciences jumps 8% as USFDA approves Apalutamide tablets
Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...
EquityBulls6d
Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.